Fatty liver

Diseases

Statins Offer Promising Therapeutic Avenue for Non-Alcoholic Fatty Liver Disease Management

Recent research on non-alcoholic fatty liver disease (NAFLD) has demonstrated the efficacy of statins in reducing liver enzymes, improving histological features, and attenuating disease progression in patients with NAFLD. Statins target key pathogenic pathways in NAFLD, including the inhibition of sterol regulatory element-binding proteins (SREBPs), activation of peroxisome proliferator-activated receptor-alpha